Markus Vossman

R&D

Markus Vossman, Germany general manager at Illumina, discusses innovative genomic applications and projects in the region.

News

Novo has moved a step closer to EU approval of its long-acting haemophilia A therapy, Frehemgo, which could be a future blockbuster.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.